Table 2 Patient characteristics of Navios EX validation samples
From: Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
Characteristic |  | Non-cancer, n = 26 | Cancer, n = 6 |
|---|---|---|---|
Patient demographics | |||
 Age—years | mean (Range) | 65 (52–79) | 64 (49–76) |
 Male | n (%) | 15 (57.8) | 6 (100) |
 Female | n (%) | 11 (42.3) | 0 |
Race | |||
 White | n (%) | 20 (76.9) | 5 (83.3) |
 Non-white | n (%) | 2 (7.7) | 1 (16.7) |
 Not available | n (%) | 4 (15.4) | 0 |
Ethnicity | |||
 Hispanic | n (%) | 5 (19.2) | 0 |
 Non-Hispanic | n (%) | 17 (65.4) | 6 (100) |
 Not available | n (%) | 4 (15.4) | 0 |
Smoking status | |||
 Never | n (%) | 0 | 1 (16.7) |
 Former | n (%) | 14 (53.8) | 2 (33.3) |
  Pack years | mean (SD) | 60.1 (27.3) | 90 and 25a |
 Current | n (%) | 11 (42.4) | 3 (50.0) |
  Pack years | mean (SD) | 52.4 (27.7) | 75.0 (37.0) |
 Not available | n (%) | 1 (3.8) | 0 |
Comorbidities | |||
 COPD | n (%) | 9 (34.6) | 3 (50.0) |
 Emphysema | n (%) | 4 (15.4) | 1 (16.7) |
 Asthma | n (%) | 1 (3.8) | 0 |
 Bronchitis | n (%) | 1 (3.8) | 0 |
 Cancer | n (%) | 1 (3.8) | 2 (33.3) |
 Not available | n (%) | 2 (7.7) | 0 |